Completed NA INTERVENTIONAL 2-arm NCT03763669

Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes Diet Treated (MYOGDM)

Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study

Sponsor: University of Messina

Conditions Gestational Diabetes

Interventions Myoinositol Placebo (for myoinositol)

Updated 6 times since 2019 Last updated: Mar 23, 2020 Started: Nov 14, 2018 Primary completion: Mar 15, 2020 Completion: Mar 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gestational Diabetes, this trial is completed. The trial is conducted by University of Messina and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2020 — Apr 2020 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2019 — Jan 2020 [monthly]

Recruiting NA

First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Messina

Data source: University of Messina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Messina, Italy